| Gemma M Burke, CRNA | |
|
701 N 1st St, Springfield, IL 62781-0001 | |
| (217) 788-3754 | |
| (217) 788-7071 |
| Full Name | Gemma M Burke |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 701 N 1st St, Springfield, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114993714 | NPI | - | NPPES |
| 016800 | Other | CCNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gemma M Burke, CRNA 701 N 1st St, Springfield, IL 62781-0001 Ph: (217) 788-3754 | Gemma M Burke, CRNA 701 N 1st St, Springfield, IL 62781-0001 Ph: (217) 788-3754 |
News Archive
In celebration of Kavli Prize Week, the Norwegian University of Science and Technology (NTNU), the Norwegian Academy of Science and Letters, and the Kavli Foundation will hold a series of lectures and events on 9 September 2010 in Trondheim, Norway at the NTNU campus. The event features a number of 2010 Kavli Prize Laureates. The festivities continue after the official celebration, with two symposia sponsored by NTNU, one in neuroscience and one in nanoscience.
When the weather heats up, many nature lovers head to a national park or forest for a summertime hiking or camping trip. A little preparation and an understanding of safety can go a long way to avoid potential pitfalls that come with enjoying Mother Nature.
Seqirus announced today that the US Food and Drug Administration has approved Fluad (Influenza Vaccine, Adjuvanted) to help protect those aged 65 years and older against seasonal influenza. Fluad is the first adjuvanted seasonal influenza vaccine approved in the United States; it was specifically developed for the adult population aged 65 and older.
Boston Scientific Corporation today announced the completion of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of the Company's fourth-generation SYNERGY™ Coronary Stent. The randomized, single-blind, non-inferiority trial will compare the SYNERGY Stent to the PROMUS Element™ Everolimus-Eluting Coronary Stent in patients with a single de novo native coronary artery lesion.
› Verified 7 days ago
Douglas Mcdonald Childs, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 800 E Carpenter St, Springfield, IL 62704 Phone: 217-525-5643 Fax: 217-544-2521 | |
Carol A Gorden, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 701 N 1st St, Springfield, IL 62781 Phone: 217-788-3754 Fax: 217-788-7071 | |
Ann R Larson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 701 N 1st St, Anesthesia Department, Springfield, IL 62781 Phone: 217-788-3754 Fax: 217-788-7071 | |
Jenna Younker, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 E Carpenter St, Springfield, IL 62702 Phone: 217-525-5643 Fax: 217-544-2521 | |
Kelsey A Wallace, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 701 N 1st St, Springfield, IL 62781 Phone: 217-788-3000 | |
Delores A Gallo, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1025 S 6th St, Springfield, IL 62703 Phone: 217-528-7541 | |
Larry D. Sartore, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 800 East Carpenter Street, Room 2k64, Springfield, IL 62769 Phone: 217-525-5643 Fax: 217-544-3311 |